ATE373485T1 - Herstellungsverfahren für kombinationsimpfstoffe - Google Patents

Herstellungsverfahren für kombinationsimpfstoffe

Info

Publication number: ATE373485T1
Authority: AT; Austria
Prior art keywords: production process; combination vaccines; vaccines; combination; production
Prior art date: 2001-01-10

Application number

AT02729589T

Other languages

English (en)

Inventor

Kyu-Wan Kim

Hyi-Jeong Ji

Youn-Kyeong Lee

Wan-Kyu Kim

Hee-Ku Lee

Won-Kyum Kim

Original Assignee

Lg Life Sciences Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-10

Filing date

2002-01-09

Publication date

2007-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19704448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE373485(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-01-09 Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd

2007-10-15 Application granted granted Critical

2007-10-15 Publication of ATE373485T1 publication Critical patent/ATE373485T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0017—Combination vaccines based on whole cell diphtheria-tetanus-pertussis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Mycology (AREA)
Virology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT02729589T 2001-01-10 2002-01-09 Herstellungsverfahren für kombinationsimpfstoffe ATE373485T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR10-2001-0001290A KR100401423B1 (ko)	2001-01-10	2001-01-10	혼합 백신의 제조 방법

Publications (1)

Publication Number	Publication Date
ATE373485T1 true ATE373485T1 (de)	2007-10-15

Family

ID=19704448

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02729589T ATE373485T1 (de)	2001-01-10	2002-01-09	Herstellungsverfahren für kombinationsimpfstoffe

Country Status (21)

Country	Link
US (2)	US20040048336A1 (de)
EP (1)	EP1349572B1 (de)
JP (1)	JP3977257B2 (de)
KR (1)	KR100401423B1 (de)
CN (1)	CN1228086C (de)
AR (1)	AR032391A1 (de)
AT (1)	ATE373485T1 (de)
AU (1)	AU2002219693B2 (de)
BR (1)	BR0206391A (de)
CA (1)	CA2434421C (de)
DE (1)	DE60222529T2 (de)
ES (1)	ES2291466T3 (de)
IL (1)	IL156791A0 (de)
MX (1)	MXPA03006154A (de)
MY (1)	MY143688A (de)
PE (1)	PE20020758A1 (de)
PL (1)	PL211005B1 (de)
RU (1)	RU2264226C2 (de)
UY (1)	UY27118A1 (de)
WO (1)	WO2002055105A1 (de)
ZA (1)	ZA200305072B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0642355T3 (da)	1992-05-23	1998-11-30	Smithkline Beecham Biolog	Kombinerede vacciner, der omfatter hepatitis B-overfladeantigen og andre antigener
GB0505996D0 (en)	2005-03-23	2005-04-27	Glaxosmithkline Biolog Sa	Fermentation process
GB0522765D0 (en)	2005-11-08	2005-12-14	Chiron Srl	Combination vaccine manufacture
EP2035022B1 (de) *	2006-05-31	2012-04-11	Baroncini, Luciana	Pharmazeutische verwendung von immunologisch mit diphtherie-toxin korrelierten proteinmolekülen
GB0616306D0 (en) *	2006-08-16	2006-09-27	Novartis Ag	Vaccines
CN103585624A (zh) *	2006-09-07	2014-02-19	葛兰素史密丝克莱恩生物有限公司	疫苗
GB0822633D0 (en) *	2008-12-11	2009-01-21	Novartis Ag	Formulation
IT1398927B1 (it)	2009-06-25	2013-03-28	Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi	Espressione batterica di un gene artificiale per la produzione di crm197 e derivati.
GB0917647D0 (en)	2009-10-08	2009-11-25	Glaxosmithkline Biolog Sa	Expression system
CN102363041A (zh) *	2011-11-17	2012-02-29	成都欧林生物科技股份有限公司	不含防腐剂疫苗的制作工艺
KR101518473B1 (ko)	2013-03-14	2015-05-07	(주)바이오인디스트	애완견의 바이러스성 전염병 예방 및 치료용 복합 난황 항체 조성물 및 그 제조방법
AR102547A1 (es)	2014-11-07	2017-03-08	Takeda Vaccines Inc	Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
AU2015252119A1 (en)	2014-11-07	2016-05-26	Takeda Vaccines, Inc.	Hand, foot, and mouth vaccines and methods of manufacture and use thereof
KR20220076405A (ko) *	2020-11-30	2022-06-08	주식회사 엘지화학	알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU188847B (en) *	1983-02-22	1986-05-28	Human Oltoanyagtermeloe Es Kutato Intezet,Hu	Process for producing liophylized combined vaccines
CA1213234A (en) *	1983-03-30	1986-10-28	Akihiro Ginnaga	Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4649192A (en) *	1985-05-30	1987-03-10	Smith Kline-Rit	Method for the isolation and purification of hepatitis B surface antigen using polysorbate
JP2661044B2 (ja) *	1986-06-17	1997-10-08	カイロンコーポレイション	肝炎δの診断薬およびワクチン
JPH085804B2 (ja) *	1988-04-28	1996-01-24	財団法人化学及血清療法研究所	Ａ型及びｂ型肝炎混合アジュバントワクチン
EP0484621A3 (en) *	1990-07-11	1992-08-26	American Cyanamid Company	Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
DK0642355T3 (da) *	1992-05-23	1998-11-30	Smithkline Beecham Biolog	Kombinerede vacciner, der omfatter hepatitis B-overfladeantigen og andre antigener
WO1997035612A1 (fr) *	1996-03-23	1997-10-02	The Research Foundation For Microbial Diseases Of Osaka University	Antigene a fragment fonctionnel de la toxine du tetanos, et vaccin contre le tetanos
GB9611501D0 (en) *	1996-06-03	1996-08-07	Smithkline Beecham Biolog	Vaccine compositions
JP3280675B2 (ja) *	1996-07-02	2002-05-13	コノートラボラトリーズリミテッド	多価ｄｔｐポリオワクチン
GB9623233D0 (en) *	1996-11-07	1997-01-08	Smithkline Beecham Biolog	Vaccine composition
ATE316797T1 (de) *	1997-09-15	2006-02-15	Sanofi Pasteur Msd	Verfahren zur herstellung multivalenter impfstoffe
GB9806456D0 (en) *	1998-03-25	1998-05-27	Smithkline Beecham Biolog	Vaccine composition

2001
- 2001-01-10 KR KR10-2001-0001290A patent/KR100401423B1/ko active IP Right Grant
2002
- 2002-01-08 MY MYPI20020056A patent/MY143688A/en unknown
- 2002-01-09 AU AU2002219693A patent/AU2002219693B2/en not_active Ceased
- 2002-01-09 CN CNB028035933A patent/CN1228086C/zh not_active Expired - Fee Related
- 2002-01-09 PL PL369433A patent/PL211005B1/pl not_active IP Right Cessation
- 2002-01-09 RU RU2003124660/15A patent/RU2264226C2/ru active
- 2002-01-09 US US10/465,930 patent/US20040048336A1/en not_active Abandoned
- 2002-01-09 UY UY27118A patent/UY27118A1/es not_active IP Right Cessation
- 2002-01-09 AR ARP020100060A patent/AR032391A1/es unknown
- 2002-01-09 ES ES02729589T patent/ES2291466T3/es not_active Expired - Lifetime
- 2002-01-09 JP JP2002555838A patent/JP3977257B2/ja not_active Expired - Fee Related
- 2002-01-09 WO PCT/KR2002/000034 patent/WO2002055105A1/en active IP Right Grant
- 2002-01-09 BR BR0206391-3A patent/BR0206391A/pt active Search and Examination
- 2002-01-09 MX MXPA03006154A patent/MXPA03006154A/es active IP Right Grant
- 2002-01-09 AT AT02729589T patent/ATE373485T1/de not_active IP Right Cessation
- 2002-01-09 EP EP02729589A patent/EP1349572B1/de not_active Revoked
- 2002-01-09 PE PE2002000008A patent/PE20020758A1/es active IP Right Grant
- 2002-01-09 DE DE60222529T patent/DE60222529T2/de not_active Revoked
- 2002-01-09 CA CA2434421A patent/CA2434421C/en not_active Expired - Fee Related
2003
- 2003-01-09 IL IL15679103A patent/IL156791A0/xx not_active IP Right Cessation
- 2003-06-30 ZA ZA200305072A patent/ZA200305072B/en unknown
2009
- 2009-03-19 US US12/407,445 patent/US20090181050A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200305072B (en)	2003-09-17
UY27118A1 (es)	2002-08-30
CA2434421A1 (en)	2002-07-18
EP1349572B1 (de)	2007-09-19
MY143688A (en)	2011-06-30
RU2264226C2 (ru)	2005-11-20
KR100401423B1 (ko)	2003-10-17
BR0206391A (pt)	2004-07-27
EP1349572A1 (de)	2003-10-08
CA2434421C (en)	2012-02-21
CN1484531A (zh)	2004-03-24
CN1228086C (zh)	2005-11-23
AR032391A1 (es)	2003-11-05
EP1349572A4 (de)	2004-09-15
US20040048336A1 (en)	2004-03-11
DE60222529D1 (de)	2007-10-31
US20090181050A1 (en)	2009-07-16
RU2003124660A (ru)	2005-01-10
MXPA03006154A (es)	2003-09-16
JP3977257B2 (ja)	2007-09-19
PE20020758A1 (es)	2002-08-29
IL156791A0 (en)	2004-02-08
JP2004517866A (ja)	2004-06-17
PL369433A1 (en)	2005-04-18
WO2002055105A1 (en)	2002-07-18
KR20020060298A (ko)	2002-07-18
AU2002219693B2 (en)	2006-03-16
DE60222529T2 (de)	2008-06-19
ES2291466T3 (es)	2008-03-01
PL211005B1 (pl)	2012-03-30

Publication	Publication Date	Title
DE60205413D1 (de)	2005-09-15	Herstellungsverfahren
NO20033902D0 (no)	2003-09-04	Fremgangsmåte for fremstilling av mellomdestillater
DE60336429D1 (de)	2011-04-28	HERSTELLUNGSVERFAHREN FÜR Ta-SPUTTERTARGET
DE60225161D1 (de)	2008-04-03	Zinkgewinnungsverfahren
DE50110649D1 (de)	2006-09-14	Zubereitung für restenoseprophylaxe
DE60134954D1 (de)	2008-09-04	Produktionanordnung für Halbleiter
DE60232513D1 (de)	2009-07-16	Verbessertes zunderkonditionierverfahren
NO20033887D0 (no)	2003-09-02	Fremgangsmåte for fremstilling av stöpestykker
DE60216133D1 (de)	2006-12-28	Reifenherstellungsverfahren
DE60235767D1 (de)	2010-05-06	Sublimationsmuster-giessverfahren
ATE373485T1 (de)	2007-10-15	Herstellungsverfahren für kombinationsimpfstoffe
IS7239A (is)	2004-04-29	Aðferð til framleiðslu á essítalóprami
ATE360674T1 (de)	2007-05-15	Hydrierverfahren
DE60227019D1 (de)	2008-07-24	Herstellungsverfahren für SOI-MOSFET
DE60233109D1 (de)	2009-09-10	Radidentifikator- ortungsverfahren
NO20022644D0 (no)	2002-06-05	Renseprosess
PL370512A1 (pl)	2005-05-30	Sposób wytwarzania produktu z włókna mineralnego
NO20013287L (no)	2002-12-30	FBG produksjonssystem
DE60235943D1 (de)	2010-05-27	Stahlherstellungsverfahren
DK1262451T3 (da)	2005-08-08	Fremgangsmåde til at fremstille svovldioxid
ITMI20021031A0 (it)	2002-05-14	Procedimento per preparare policarbonato-polioli
DE60207451D1 (de)	2005-12-29	Produktionsverfahren
NO20033970L (no)	2003-11-07	Fremgangsmåter for öket produksjon av pantothenat
DE60012372D1 (de)	2004-08-26	Verbesserte herstellungsmethode für acylferrocene
DE60219714D1 (de)	2007-06-06	Elektrobeschichtungsverfahren

Legal Events

Date	Code	Title	Description
2008-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties